123 related articles for article (PubMed ID: 19332433)
1. Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis.
Miranda FA; Hassumi MK; Guimarães MC; Simões RT; Silva TG; Lira RC; Rocha AM; Mendes CT; Donadi EA; Soares CP; Soares EG
J Histochem Cytochem; 2009 Jul; 57(7):665-73. PubMed ID: 19332433
[TBL] [Abstract][Full Text] [Related]
2. Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.
Hassumi-Fukasawa MK; Miranda-Camargo FA; Guimarães MC; Simões RT; Donadi EA; Soares CP; Soares EG
Eur Arch Otorhinolaryngol; 2012 Jul; 269(7):1795-804. PubMed ID: 22310835
[TBL] [Abstract][Full Text] [Related]
3. Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness.
Silva TG; Crispim JC; Miranda FA; Hassumi MK; de Mello JM; Simões RT; Souto F; Soares EG; Donadi EA; Soares CP
Histol Histopathol; 2011 Dec; 26(12):1487-97. PubMed ID: 21972088
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus in early laryngeal carcinoma.
Baumann JL; Cohen S; Evjen AN; Law JH; Vadivelu S; Attia A; Schindler JS; Chung CH; Wirth PS; Meijer CJ; Snijders PJ; Yarbrough WG; Slebos RJ
Laryngoscope; 2009 Aug; 119(8):1531-7. PubMed ID: 19489068
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma.
de Oliveira DE; Bacchi MM; Macarenco RS; Tagliarini JV; Cordeiro RC; Bacchi CE
Am J Clin Pathol; 2006 Aug; 126(2):284-93. PubMed ID: 16891205
[TBL] [Abstract][Full Text] [Related]
6. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
Jo VY; Krane JF; Pantanowitz L; Monaco SE
Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
[TBL] [Abstract][Full Text] [Related]
7. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin.
Begum S; Gillison ML; Ansari-Lari MA; Shah K; Westra WH
Clin Cancer Res; 2003 Dec; 9(17):6469-75. PubMed ID: 14695150
[TBL] [Abstract][Full Text] [Related]
9. Presence of human papillomavirus in squamous cell laryngeal carcinomas. A study of thirty-nine cases using polymerase chain reaction and in situ hybridization.
Lie ES; Karlsen F; Holm R
Acta Otolaryngol; 1996 Nov; 116(6):900-5. PubMed ID: 8973730
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain.
Rodrigo JP; Hermsen MA; Fresno MF; Brakenhoff RH; García-Velasco F; Snijders PJ; Heideman DA; García-Pedrero JM
Cancer Epidemiol; 2015 Feb; 39(1):37-41. PubMed ID: 25468644
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 upregulation during tumor progression in head and neck cancer.
Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma.
Türköz HK; Oksüz H; Yurdakul Z; Ozcan D
Endocr Pathol; 2008; 19(2):92-6. PubMed ID: 18581271
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens.
Torrente MC; Ampuero S; Abud M; Ojeda JM
Acta Otolaryngol; 2005 Aug; 125(8):888-93. PubMed ID: 16158538
[TBL] [Abstract][Full Text] [Related]
14. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
15. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
Baser E; Can F; Unlukaplan M; Ayhan A
Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal dysplasia and the human papillomavirus.
Lindeberg H; Krogdahl A
Clin Otolaryngol Allied Sci; 1997 Aug; 22(4):382-6. PubMed ID: 9298618
[TBL] [Abstract][Full Text] [Related]
17. Usefulness and efficiency of formalin-fixed paraffin-embedded specimens from laryngeal squamous cell carcinoma in HPV detection by IHC and PCR/DEIA.
Morshed K; Polz-Dacewicz M; Szymański M; Smoleń A
Folia Histochem Cytobiol; 2010 Sep; 48(3):398-402. PubMed ID: 21071345
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
19. Association between human papillomavirus infection and laryngeal squamous cell carcinoma.
Morshed K
J Med Virol; 2010 May; 82(6):1017-23. PubMed ID: 20419817
[TBL] [Abstract][Full Text] [Related]
20. Low detection rate of HPV in oral and laryngeal carcinomas.
Matzow T; Boysen M; Kalantari M; Johansson B; Hagmar B
Acta Oncol; 1998; 37(1):73-6. PubMed ID: 9572657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
